Vobarilizumab (INN; development code ALX0061) is a humanized bispecific nanobody (Llama-derived heavy-chain only (Vhh) antibody) designed for the treatment...
3 KB (213 words) - 01:47, 29 October 2023
Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric +...
38 KB (4,316 words) - 10:24, 26 August 2024
Visilizumab Nuvion mab humanized CD3 Crohn's disease, ulcerative colitis Vobarilizumab scFv humanized IL-6 receptor inflammatory autoimmune diseases Volociximab...
136 KB (4,020 words) - 06:13, 27 September 2024
Tocilizumab Toralizumab Tregalizumab Vatelizumab Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric +...
2 KB (87 words) - 01:28, 30 May 2023